Articles
Pharmalicensing brings you advice, commentary and analysis from industry experts.
- Articles
- Browse
Articles
Identifying the best partner for technology or clinical compounds is one of the most time consuming and frustrating aspects of deal making More
Genus Pharmaceuticals has recently became the wholly owned UK subsidiary of STADA Arzneimittel AG, a German company with a large portfolio of existing generic drugs, as well as an impressive number in its pipeline. More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2010 - 25 pages - $995
May 2010 - 27 pages - $995
May 2010 - 26 pages - $995
May 2010 - 26 pages - $995
May 2010 - 26 pages - $995
May 2010 - 26 pages - $995
May 2010 - 26 pages - $995
May 2010 - 26 pages - $995
Nov 2010 - 27 pages - $99
Dec 2010 - 58 pages - $5,700
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us